INDP
Indaptus Therapeutics, Inc.
+0.27 (+8.57%)3.49USD428K成交股數464M市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 363K | 491K | 1.5M | 2.2M | 2.8M | 2.5M | 1.5M | 1.7M | 1.6M | 2.2M | 1.5M | 1.9M |
| 銷售管理費用 | 1.4M | 1.7M | 1.1M | 2.3M | 1.8M | 1.7M | 1.7M | 2.4M | 2.4M | 2.0M | 2.0M | 2.6M |
| 營業利益 | −1.8M-60% | −2.2M-48% | −2.6M-16% | −4.5M+8% | −4.6M+16% | −4.2M-2% | −3.1M-10% | −4.1M-8% | −3.9M | −4.2M | −3.5M | −4.5M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −1.8M-60% | −2.5M-38% | −3.0M-3% | −5.2M+30% | −4.5M+19% | −4.1M+5% | −3.1M-5% | −4.0M-6% | −3.8M | −3.9M | −3.2M | −4.3M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.02-100% | -0.23-99% | -2.98-67% | -9.09-31% | -9.11+1924% | -22.31+4647% | -9.04+2218% | -13.16+2480% | -0.45 | -0.47 | -0.39 | -0.51 |
| 稀釋股數 | 116M | 11.0M | 997K | 575K | 498K | 334K | 340K | 305K | 8.4M | 8.4M | 8.4M | 8.4M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 7.6M | 1.5M | 5.8M | 6.2M | 3.9M | 5.8M | 7.4M | 7.3M | 9.7M | 16.0M | 12.7M | 6.8M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 12.0M | – | 6.8M | 6.8M | 5.4M | 7.3M | 8.2M | 8.1M | 10.9M | 17.8M | 20.8M | 23.1M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 615K | – | – | – | – | 3.4M | 2.2M | 2.0M | 1.6M | 2.5M | 2.2M | 2.0M |
| 股東權益 | 11.4M | 1.2M | 4.6M | −1.7M | 2.8M | 3.9M | 6.0M | 6.2M | 9.4M | 15.3M | 18.6M | 21.2M |
| 負債比 | 5.1% | – | – | – | – | 46.2% | 27.1% | 24.1% | 14.5% | 13.8% | 10.6% | 8.5% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −7.0M | – | – | −5.0M+28% | – | – | – | −3.9M | – | – | −5.0M |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −20.8M | –% | -21.58 | – |
| FY2024 | – | – | −15.0M | –% | -44.96 | – |
| FY2023 | – | – | −15.4M | –% | -1.83 | – |
| FY2022 | – | – | −14.3M | –% | -1.73 | – |
| FY2021 | – | – | −7.7M | –% | -1.89 | −11.3M |
| FY2020 | – | – | −3.6M | –% | -1.84 | – |